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 Trauma is the leading cause of death for people between 0 and 45 years of age. 
An important step in the management of trauma patients is the replacement of a large 
volume of fluids, typically with normal saline. However, normal saline has been 
implicated in the development of metabolic derangements that may contribute to a large 
proportion of deaths in trauma patients. In this study, we will examine whether less acidic 
solutions that contain buffers can improve survival in trauma patients compared to 
normal saline. We will perform a double-blind randomized control trial to determine 
whether fluid replacement with Lactated Ringer's solution or a solution of 0.45% 
normal saline and sodium bicarbonate in a prehospital setting can improve survival 
in trauma patients compared to normal saline. The insights gleaned from this study 













Chapter 1: Introduction 
1.1 Background 
Traumatic injuries are, far and away, the leading cause of death in individuals age 
0 years to 45 years.1 A common consequence of trauma is profound hypovolemia as a 
result of blood loss and vascular hyperpermeability.2 In order to maintain hemodynamic 
stability in these patients, fluid resuscitation is often required. The most ubiquitous fluid 
used to resuscitate these patients is normal saline (0.9% NaCl).3,4 
1.1.1 Acidosis in Trauma as it Relates to Fluid Resuscitation  
Despite its predominance as the most utilized crystalloid in trauma patients, the 
use of normal saline is commonly implicated in the exacerbation and development of 
metabolic derangements including hyperchloremic acidosis and dilutional 
coagulopathies.3,5 Normal Saline is relatively acidic (pH ~4.5-5.0) when compared to 
some other alternative crystalloids including Lactated Ringer’s Solution (pH ~6.5).6 In 
the body, large volumes of normal saline increase the concentration of unpaired chloride 
ions which contribute to hyperchloremic acidosis due to their strong ionic influence.7 
Trauma patients are already at high risk for developing acidosis as lactic acid 
accumulates quickly in the body due to poor perfusion that is associated with even 
relatively minor traumatic injuries. Certain traumatic injuries such as rib fractures may 
indirectly contribute to respiratory acidosis as a result of hypoventilation secondary to 
painful inspiration.8 The acidic profile of normal saline is notable for many reasons but 
perhaps the most significant of which is its effects on coagulation. Previous studies have 
noted that coagulation factors require a relatively narrow pH range to respond 
appropriately.9 This is significant in trauma patients that may have multiple bleeding 
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injuries contributing to their hypotension as delays to coagulation can exacerbate 
exsanguination and hemodynamic collapse. It has also been observed that large volumes 
of normal saline can contribute to systemic vasodilation, which is highly problematic in 
patients that require intravenous fluid to compensate for volume loss.6 
1.1.2 Sodium Bicarbonate Solutions and Lactate Ringers  
Lactated Ringers (LR) and Normal Saline (NS) are among several different 
crystalloids that are considered for fluid resuscitation. Another less common approach to 
fluid resuscitation involves the dilution of sodium bicarbonate in 0.45% NaCl to create a 
sodium bicarbonate solution (SBS). One study by Hashemi et al described the process of 
mixing this solution by adding three 50 ml vials of NaHCO3 solution into 850 mL of 
0.45% NaCl (1/2 NS) solution to get to a final concentration of 1.3% sodium bicarbonate 
solution10. In order to achieve this final concentration, 8.4% bicarb vials would be 
required. The purpose of this custom solution was to better account for physiological 
changes in pH and osmolarity associated with blood loss in the context of surgical 
hemorrhage. In the aforementioned small study (n=66) hemodynamic stability was 
observed more in the SBS group when compared to LR. One benefit of this custom 
solution is its hypertonicity compared to lactated ringer’s which is relatively hypotonic 
(272 mOsm/L)6. Lactated ringer’s low osmolarity/tonicity makes it a controversial choice 
for patients with traumatic brain injury as a hypotonic solution may increase intracranial 
pressure as a result of diffusion; however, this link has not been established definitively.11 
There is significant reason to believe that Lactated Ringer’s or sodium 
bicarbonate solutions may be better choices for fluid resuscitation in trauma patients. 
While the electrolyte profile of LR is not identical to that of plasma, it more closely 
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resembles the ion composition of plasma than normal saline, and the concentration of 
chloride in LR mirrors physiologic chloride levels, reducing the concern for 
hyperchloremic acidosis6. Some data also suggest that lactate may be a preferred energy 
source in states characterized by ischemia, including trauma12. Perhaps the most 
significant benefit of lactate is its ability to be metabolized into weakly basic bicarbonate 
ions in the liver that can correct acidosis13. As mentioned earlier SBS is hypertonic and 
may be safer in patients with traumatic brain injury to limit edema. It also contributes 
more to alkalization than LR. One liter of lactated ringer’s contains 130 mEq of lactate 
which is converted 1:1 to bicarbonate13. SBS contains 150 ml of 8.4% sodium 
bicarbonate which contains 1 mEq of bicarbonate/mL, increasing the availability of 
bicarbonate ions by ~15% compared to LR (130 mEq vs 150 mEq). SBS also has the 
benefit of not requiring metabolism from lactate to bicarbonate, as some research 
suggests that lactate metabolism may be impaired in critical illness due to the oxygen-
dependent nature of the acetate and lactate metabolism pathways7. 
1.1.3 Notable Findings of Past Studies 
For a myriad of physiological reasons, there is significant reason to believe that 
either of the solutions mentioned above may incur a mortality benefit when compared to 
normal saline. One RCT attempted to simulate traumatic blood loss by evaluating healthy 
patients following blood donation. These patients were randomized to a no-fluid group, 
Lactated Ringer’s, or normal saline. The results of this RCT show that patients receiving 
normal saline had a statistically significantly lower blood pH than those that did not 
receive replacement fluids or those that received LR, supporting the idea that normal 
saline can contribute to acidosis. The same paper also demonstrated statistically 
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significant increases in serum levels of bicarbonate in the LR group compared to the no 
fluid or NS group.7 
The study that was the most similar to the study that will be proposed here was a 
randomized controlled trial conducted by Young et al that compared normal saline to an 
isotonic crystalloid called Plasma-Lyte A, using the mean change in base excess as its 
primary outcome. Once again, this study demonstrated that the administration of a 
balanced crystalloid solution was associated with more favorable metabolic profiles when 
compared to normal saline, including acid-base balance and chloride levels14. 
1.2 Statement of the Problem 
 The prevalence of traumatic injuries and the metabolic complications associated 
with normal saline has led many researchers and clinicians to posit that a different fluid 
should replace normal saline as the standard of care in these patients. While these 
theories have been proposed there has not yet been a randomized controlled trial that has 
evaluated mortality as a primary outcome when comparing normal saline to lactated 
ringer’s or SBS. 
1.3 Goals and Objectives 
The study will allow us to determine if there is a difference in in-hospital 
mortality in trauma patients that receive normal saline compared to those that receive 
SBS or LR as the primary outcome. Secondary outcomes will include the need for 
intubation, blood products, length of hospital stay, and length of intubation (when 
required). The goals of the study are to fill the gaps in the literature that are described 
above. In addition to the novel study design, this will be the first study that begins the 
intervention in the field. Previously mentioned studies such as Young et al began the 
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fluid intervention on arrival to the hospital after EMS had already administered their 
fluids. By randomizing the fluid selection in the field and carrying that fluid through 
initial stabilization in the hospital, there will be continuity of the intervention from the 
time that the treatment is initiated. Not only will early intervention contribute to the 
continuity of management, but it will also, theoretically, allow for the early accumulation 
of bicarbonate before acidosis begins to develop5. 
Randomized Controlled Trials are uncommon in trauma management because of 
the difficulty in obtaining informed consent from patients that are incapacitated or 
otherwise disoriented following trauma. In order to conduct this research, we plan to 
utilize the FDA’s exception for informed consent (EFIC) that allows for a subject’s 
enrollment in a study before consent can be obtained in cases where an intervention is 
required urgently, as is the case with fluid resuscitation in trauma patients.15,16 
1.4 Hypothesis 
We hypothesize that trauma patients with an injury severity score (ISS) of 16 or 
greater that receive normal saline as their primary resuscitative fluid will have 
significantly higher rates of mortality compared to those that receive Lactated Ringer’s or 
the Sodium Bicarbonate Solution. We expect patients that receive LR or SBS to have in-
hospital mortality rates that are approximately 14% lower than those that receive NS. 
1.5 Definitions 
1. Lactated Ringer’s is an intravenous fluid used for volume resuscitation that contains 
sodium, chloride, potassium, calcium, and lactate. This solution will be used as one of the 
three arms in this study. 
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2.  Normal Saline (also known as 0.9% sodium chloride) is an intravenous fluid used for 
volume resuscitation that contains sodium and chloride. This solution will be used as one 
of the three arms in this study. 
3. Sodium Bicarbonate is a well-known buffer that will be added to 0.45% sodium 
chloride (otherwise known as “half normal saline”) to create the sodium bicarbonate 
solution that will be used for volume resuscitation as one of the arms of this study. 
4. Injury Severity Score is a scale utilized to assess the severity of a patient’s traumatic 
injuries. The scale considers injuries to different anatomical regions and ranges from 1-
75, with scores of 16 or more being considered “severe”. 
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Chapter 2: Review of the Literature 
2.1 Introduction 
 A systematic literature review was performed on the following databases: 
PubMed, Cochrane, Scopus, and Embase. The literature search was performed in 
December of 2020 using the keywords Normal Saline, Sodium Bicarbonate, Lactated 
Ringers, Trauma, and Metabolic Acidosis. Synonyms for normal saline included “0.9% 
saline”, and “0.9% NaCl”. Synonyms for sodium bicarbonate included “carbonic acid 
monosodium salt”, “sodium hydrogen carbonate”, and “baking soda”. Synonyms for 
Lactated Ringers included “lactate, ringer's”, “Hartmann’s solution”, “lactated 
ringer’s solution”, and “ringers lactate”. Synonyms for trauma included “injuries and 
wounds”, “research-related injuries”, “injuries”, “wounds”, “hemorrhagic shock”, 
“traumatic brain injury”, “cerebrovascular trauma”, “head injuries, penetrating”, “war-
related injuries”, “head injuries, closed”, “hypovolemic shock” and “burns”. Synonyms 
for metabolic acidosis included “acidosis”. Due to the limited number of randomized 
controlled trials and human studies, the literature search includes animal research and 
observational studies. Review articles were utilized to describe important physiological 
concepts. The articles included in the literature review were published no earlier than 
2011. Only articles that were available in English were included. 
2.2 Complications Associated with Trauma 
 Trauma is the leading cause of death between the ages of 0 and 45 years in the 
United States. 1 The worldwide burden of death due to trauma is staggering. In 2010 there 
were 5.1 million deaths due to injuries which accounted for nearly one out of every 10 
deaths. 2 Despite continual advances in safety and technology in the automotive and 
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medical industries, the rate of deaths that occur within minutes following trauma has 
remained relatively static over the last several decades, at around 50%.3 The purpose of 
this study is to evaluate the management of trauma patients that survive past this 
“immediate death” window, many of which go on to develop severe metabolic 
complications that can result in life-threatening complications such as hemorrhage and 
multiorgan system failure.  
 The pathology of complications associated with trauma is complex and it would 
be impossible to describe all of the physiological responses that may occur following 
trauma in the scope of this study, however, it is important to recognize several of the 
most notable derangements and how standard interventions may influence, and 
exacerbate those derangements. Despite the ubiquity of traumatic injury, there are very 
few studies that have attempted to describe the physiology of multi-system injury or 
hemorrhage in humans due to practical and ethical considerations. For this reason, many 
of the metabolic responses that are theorized in humans have been observed in animal 
models.  
2.2.1 Acidosis 
 Perhaps the most significant and notable physiological response to trauma in the 
context of this study is the development of metabolic acidosis. The cause of this acidosis 
is cellular hypoperfusion, the etiology of which is multifactorial. 4-6 One such reason for 
decreased blood supply to end organs is obvious; many trauma patients suffer from 
hemorrhage. As total blood volume decreases, perfusion suffers. Further exacerbating 
hemorrhage, there are documented physiological changes at the cellular and molecular 
level that can hinder coagulation. One such complication observed in rats with traumatic 
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brain injury (TBI) is the inhibition of the adenosine diphosphate and arachidonic acid 
pathways that are mediators of platelet aggregation, an important step in the formation of 
blood clots that could otherwise stop, or slow bleeding. 4 Another significant mediator of 
poor perfusion is vasoconstriction. During physical trauma, there is a significant 
sympathetic nervous system response, mediated by the release of endogenous 
catecholamines. These catecholamines have several physiologically beneficial effects in 
trauma such as helping to maintain mean arterial blood pressure (MAP) through inotropic 
effects on the heart and an increase in systemic vascular resistance (SVR), however, this 
increase in SVR is achieved through vasoconstriction.7 On their own a decrease in blood 
volume or vasoconstriction can reduce end-organ perfusion. Many patients suffering 
from trauma-related injuries have both. As tissues receive less blood flow, they become 
hypoxic and must convert from aerobic cellular metabolism to anaerobic metabolism. 5,6 
Byproducts of this anaerobic metabolism are ultimately converted into compounds that 
contribute to metabolic acidosis.8 A study by Raffee et al identified that several 
coagulation markers including prothrombin time (PT) and partial thromboplastin time 
(PTT) were elevated in patients that had arterial blood gas suggestive of acidemia. 6 This 
finding suggests that there is potential for a dangerous cycle of hemorrhage leading to 
acidosis leading to decreased coagulability and, consequently, worsening hemorrhage. 
Furthermore, a study by Epstein et al found that patients with isolated traumatic brain 
injury had significantly greater mortality when they had an elevated INR (> 1.3) 
compared to those with a normal INR (45.1% vs 12%, p < 0.01), indicating that acidosis 




 Beyond the known physiological effects of acidemia on patients suffering from 
traumatic injury, several studies indicate that acidosis identified via arterial or venous 
blood levels are significant predictors of trauma-related death. A study by Shane et al 
found that a statistically significant number of patients with low pH (< 7.32) or low 
bicarbonate (<21 mmol) died as a result of secondary organ failure (p=.04 and p=.02 
respectively).10 The early appropriate care (EAC) protocol is a system used to categorize 
patients into low-risk or high-risk groups of developing complications or succumbing to 
their injuries.11,12 EAC stratifies risk through blood levels of three markers associated 
with acid-base balance. For a patient to be stratified into the high-risk group patients must 
meet all three criteria (pH <7.25, Base excess <-5.5, Lactate >4).11 A study by 
Halvachizadeh et al found that EAC has a statistically significant predictive capability in 
terms of death from multiorgan failure (OR 2.1, p-value .04) and death within 72 hours 
(OR 1.5, p-value <0.001) when comparing high-risk groups from low-risk groups.12 Gale 
et al also note that initial lactate levels are correlated with outcome.13 
2.2.2 Other Complications Associated with Trauma 
 While acidosis is an important complication with several systemic ramifications it 
is not the only physiological response that plays a role in the outcomes of trauma patients. 
Exsanguination due to traumatic hemorrhage can result in hypothermia which has been 
implicated in coagulopathies. 14-18 It should also be noted that hemodilution on its own 
does not appear to account for the coagulopathic effects seen in hypothermic trauma 
patients.15 Beyond coagulopathies, hypothermia has been implicated in hypoxia, 
endothelial dysfunction, cell death, and multiorgan dysfunction.18 Hypothermia is 
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considered one of the three components of the “Triad of Death” which also includes 
acidosis and coagulopathy.14,16,19 
 It has been theorized that uncontrolled hemorrhage alone (in the absence of other 
trauma) can lead to profound systemic inflammation. In a non-human primate study, 
Burdette et al found molecular markers indicating an inflammatory response following a 
surgical procedure.20 These inflammatory processes may contribute to increased 
metabolic demand in these patients who are already experiencing a large sympathetic 
nervous system response and a baseline increase in metabolic requirements.21  
 Hemorrhage in trauma patients can lead to the loss of many ions in the blood, 
namely calcium which is an important component of platelet activation, extrinsic and 
intrinsic coagulation pathways, and cardiac contractility. Not only is there a decrease in 
the absolute volume of calcium available to the body, but there is also an increase in 
calcium utilization as platelets become activated and blood clotting occurs.22 A decrease 
in calcium not only hinders coagulation but may also decrease cardiac output, as cardiac 
contractility is regulated by intracellular calcium concentrations. 23,24 
 Perhaps the most imminent complication associated with traumatic injury is 
hypotension. Trauma patients can experience hypovolemic shock as a result of significant 
blood loss. As blood pressure decreases, patients may succumb to hemorrhagic shock.25 
An analysis of war-related mortality indicated that nearly 20% of casualties experienced 
hypotension as a result of traumatic injury.26 
2.3 Fluid Resuscitation  
 Because of the imminent threat that hypotension presents to trauma patients, they 
will almost universally receive some form of IV fluid resuscitation. 27,28 At this time there 
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is significant debate regarding the most effective fluid for resuscitation following trauma. 
While several categories of fluid can be utilized for this application such as colloids and 
blood products the most common solutions in use are crystalloids such as normal saline 
or lactated ringer’s (LR).27 Even in instances of hemorrhagic shock, when treatment will 
ultimately require blood products, the initial fluid infused is still a crystalloid. The “best” 
crystalloid for IV fluid resuscitation in trauma patients is a topic of great contention and 
this study hopes to provide some clarity to that debate going forward.  
 A survey of state protocols from 2017 describes several state emergency medical 
services (EMS) protocols for fluid resuscitation of hypotensive trauma patients. Of the 
twenty-seven states with publicly available protocols, 15 states recommend normal saline 
as the fluid of choice with eleven states recommending the use of either normal saline or 
lactated ringers. One state recommended lactated ringers exclusively. Most states 
describe goal systolic blood pressures in the range of 80-100 mmHg.29 The most 
important difference between normal saline and lactated ringer’s is their classifications as 
unbalanced and balanced fluids respectively. Balanced crystalloids are closer in 
electrolyte and acid-base composition to blood plasma than normal saline which contains 
only sodium chloride.30 The theorized benefits of balanced crystalloids over normal 
saline are numerous, however to this point there have been very few trials that have 
evaluated the efficacy of these solutions in trauma patients, and at this time, there have 
been no studies that have evaluated mortality as the primary outcome. A study by Young 
et al comparing the effects of Plasma-Lyte A (another commonly used balanced 
crystalloid) vs normal saline in regards to acid-base status and serum chloride levels of 
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trauma patients demonstrated significant benefit in the balanced crystalloid arm (95% CI 
of 1.6 to 6.7 for base excess and 95% CI of -10 to -3 chloride).31  
 In addition to balanced crystalloids, there is reason to believe that there could be a 
benefit from the use of solutions that contain bicarbonate in trauma patients. The 
specifics of these proposed benefits will be described in more detail below but suffice to 
say that as the most commonly utilized physiological buffer, bicarbonate can play a 
significant role in stabilizing physiological pH.32 The specific bicarbonate-containing 
solution being proposed in this study is described in a paper by Hashemi et al. Rather 
than being purchased by a manufacturer, it is made by adding three, 50 mL vials of 8.4% 
sodium bicarbonate solution to 850 mL of 0.45% sodium chloride solution. 33 Beyond the 
proposed benefits of bicarbonate, this also yields a solution that is hyperosmolar 
compared to normal saline, a characteristic that is potentially beneficial in trauma 
patients. These benefits will be described in more detail later in this chapter.  
2.4 Issues Associated with the Infusion of Normal Saline  
 Normal saline is easily the most commonly utilized fluid utilized in volume 
replacement in trauma patients.27 It has long been used as the fluid of choice for EMS 
services and current state EMS guidelines generally favor the use of normal saline in 
trauma patients.29 Despite its prevalence in the field of trauma medicine, the use of 
normal saline has been associated with significant complications which call into question 
its utility in this setting. 30 
 As discussed previously, traumatic injuries often precipitate lactic acidosis as a 
result of poor tissue perfusion and this acidosis has wide-ranging physiological effects 
including coagulopathies. Perhaps the most frequently documented complication 
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associated with the infusion of large volumes of normal saline is hyperchloremic 
acidosis. 34-38 Contrary to conventional thought, this acidosis is not mediated through free 
proton in the normal saline solution itself. Despite having a pH as low as 4.6, the 
titratable acid in the solution is relatively small and is overcome quickly by physiological 
buffers.39 Instead, the acidic effects of normal saline are mediated through other means, 
namely an increase in strong anion concentration and the dilution of physiological 
buffers.  
The strong ion difference component of this acidosis is thought to develop 
through an increase in the concentration of strong anions, most notably chloride, as the 
concentration of chloride in normal saline is approximately 50% higher than blood 
plasma. 35 Due to the law of electroneutrality an increase in strong anion concentration is 
met with a concurrent increase in cation concentration, in this case, the dissociation of 
protons from plasma water. This causes a non-anion gap metabolic acidosis that is often 
compounded by the concurrent high anion gap acidosis that is generated through the 
previously discussed anaerobic cellular respiration generated following trauma. 36 A 
study by Lee et al found that hyperchloremia 48 hours after admission and delta chloride 
levels have been associated with mortality in trauma patients (p < 0.001).40 
The other significant contribution that normal saline makes to the development of 
acidosis is the dilution of physiological buffers, namely bicarbonate. The infusion of 
normal saline reduces the relative bicarbonate concentration in the blood. As CO2 levels 
are not influenced by blood volume, there will be an increase in carbonic acid formation 
(through respiration) relative to bicarbonate concentration, which will tend the 
physiological pH towards acidemia.39 This phenomenon has been observed with as little 
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as one liter of normal saline having a deleterious effect on base deficit in trauma 
patients.41 Meta-analysis has supported the claim that patients receiving balanced fluids 
have been shown to have a better acid-base profile and lower incidence of 
hyperchloremia than those receiving normal saline.42 
As discussed earlier, the development of acidosis contributes to coagulopathies. 
The pathogenesis of coagulation disorders is even more pronounced in patients receiving 
normal saline. A study by Darlington et al in acidosis-induced pigs demonstrates a 
decrease in clot strength and a decrease in the rate of clot formation. 43 Campbell et al 
noted that both platelet-rich plasma and platelet-poor plasma that was acidified 
demonstrated reduced clotting time, and infusion with normal saline further exacerbated 
these clotting delays while also weakening clot strength.44 The effects of normal saline on 
coagulation may extend beyond the effects of acidosis. The infusion of normal saline has 
been implicated in decreasing blood calcium levels and can even result in 
hypocalcemia.45,46 As previously discussed, reductions in serum calcium levels can have 
deleterious effects on platelet activation, both intrinsic and extrinsic clotting cascades, 
and cardiac contractility. In patients that are already at risk for developing shock and 
hemorrhage, these effects should be considered.  
Further weakening the resume for normal saline as the solution of choice in 
patients at risk for hemorrhage are its effects on the coagulation factors. In vitro models 
indicate that normal saline, even in the absence of hypothermia or acidic pH, reduces the 
rate of conversion of prothrombin to thrombin. 47 Infusion of crystalloids has also been 
associated with lower concentrations of albumin and fibrinogen while also decreasing 
hepatic albumin synthesis in swine models. 48 While detrimentally affecting important 
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components of the clotting cascade, crystalloid dilution does not appear to impair protein 
C activity in vivo, suggesting that while clotting activity may be compromised, the 
anticoagulative components of the plasma may maintain their full effect.49 It should be 
noted that the effects noted in albumin, fibrinogen, and protein C were observed with 
both balanced and non-balanced crystalloid solutions.  
In a study observing the effects of hemorrhagic shock on rats, among all the fluids 
tested for resuscitation (including hypertonic saline and lactated ringers) normal saline 
was the least effective at maintaining liver and kidney function and limiting muscle 
damage. 50 Several human studies have supported these claims, linking normal saline to 
more major adverse kidney events than compared to balanced crystalloid solutions (OR 
0.82, 95% CI 0.70-0.95).51 In addition to the potential end-organ damage associated with 
normal saline it may also influence medical management in the hyperacute setting. 
Studies observing fluid choice in patients undergoing major abdominal surgery found that 
patients receiving normal saline required significantly more vasopressor support than 
those receiving balanced solutions.52 
There are several deficiencies associated with the use of normal saline in trauma 
patients. The potential exacerbation of electrolyte imbalance, acidemia, coagulopathies 
and several other complications cannot be understated in such a critically ill patient 
population such as those that suffer severe traumatic injuries. These concerns have 
caused some to recommend abandoning the use of normal saline, questioning whether its 
use may cause more harm than good. 53,54 While there appears to be a substantial amount 
of evidence undermining the efficacy of normal saline in the management of trauma 
patients, it likely has utility in other applications such as some surgical procedures, stable 
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ED patients, and the management of DKA (where LR may prolong the duration of 
hyperglycemia). 55-57 
2.5 Lactated Ringer’s Solution 
 In patients that have experienced severe traumatic injuries, there is sufficient 
evidence to suggest that Lactated Ringer’s may be an ideal candidate in many situations. 
There are, of course, instances where the use of Lactated Ringer’s should be deferred in 
favor of another fluid. Both the proposed benefits and potential drawbacks will be 
discussed in this section. 
 As discussed previously, the development of acidosis secondary to the infusion of 
normal saline and normal physiological response to trauma can contribute to numerous 
complications in these patients. The acid-base benefits are not only linked to LR’s more 
physiological chloride concertation but also its inclusion of the conjugate base lactate. 
Lactate plays several important roles that can reduce free proton concentration such as 
binding protons to act as a base directly, being utilized by cells as an energy source to 
decrease ischemia, or by being converted into bicarbonate after lactate dehydrogenase 
mediated conversion to pyruvate.58 Several studies have now found that the same level of 
hyperchloremic acidosis that is associated with normal saline infusion is not associated 
with the infusion of LR. Ayebale et al found that patients receiving emergent C-sections 
(which may be thought of as analogous to trauma) had higher rates of acidosis when 
given normal saline compared to those given LR (RR 1.29, 95% CI 1.18-2.31). 59 Other 
studies looking at acid-base status following surgery or other settings where blood loss is 
expected (such as blood donation) support these findings, showing better levels of base 
excess in patients receiving balanced fluids compared to those receiving normal saline.60-
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62 Several studies have found that patients experiencing various forms of metabolic 
acidosis, including those with sepsis, benefit from LR by decreasing mortality rates and 
improving acid-base status. 63-65 Similarly, in children with hypovolemia secondary to 
gastroenteritis, the use of LR was associated with the best levels of plasma bicarbonate 
when compared to other fluids including normal saline. 66 
  While the effects of pH on coagulation have been discussed thoroughly, there 
have been multiple studies that have observed the benefits of LR on coagulation directly. 
Sawhney et al found that compared to normal saline, LR produced stronger clots and 
improved coagulation time in surgical patients.67 While there have been very few studies 
that have examined the effects of coagulation in humans, there have been several studies 
that utilized hemorrhage in a swine model to observe the effects of various fluids on 
coagulation. These studies indicate a better resolution of normal coagulation, improved 
clot characteristics, and time to coagulation that is closer to physiological baseline in the 
pigs receiving LR.68-70 
 In addition to its effects on coagulation, balanced fluids have been associated with 
beneficial effects in several different organ systems. According to Roquilly et al balanced 
solutions may be better in patients with brain injury (although it should be noted that LR 
should not be considered in this group as it is physiologically hypotonic, potentially 
incurring mortality risk in patients with TBI) as a result of their metabolic profile.71 In a 
study performed in rats it was observed that correcting pH can be beneficial to 
myocardial elastance and vascular responsiveness following hemorrhage.72 Similarly, it 
was observed that LR can induce antiapoptotic effects in the hearts of traumatically 
injured rats, potentially improving recovery.73 Balanced fluids have been linked to better 
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renal outcomes as well, including decreased incidence of acute kidney injury in rat 
models.74 It has also been observed that the use of LR was effective at preventing 
mitochondrial damage in both the liver and kidneys in rats with hemorrhagic shock.75 
Gastrointestinal benefits may not be isolated to the liver, as LR has been shown to reduce 
myeloperoxidase (an enzyme that produces reactive oxygen species) levels in rats 
compared to normal saline.76,77 Small studies have shown smaller volumes of LR may be 
required during resuscitation and that fluid accumulation was decreased in pediatric 
patients with septic shock.78 Overall systemic inflammation may be attenuated by the 
administration of LR,  as rats that experienced hemorrhagic shock were found to have a 
reduction of apoptosis through the blockade of the IGF II R pathway.79 In addition to its 
anti-inflammatory effects, LR can also produce antioxidative compounds. In the cytosol, 
lactate is converted into pyruvate, a powerful antioxidant that may be able to counteract 
some of the free radicals that are generated by the metabolic derangements produced 
during trauma that are outlined above.80 
 LR is a very good choice for fluid infusion and offers significantly fewer 
complications than NS, and in many cases, balanced solutions should be considered 
before the administration of normal saline. 81 There are, however, situations where LR 
may be contraindicated. While LR can be converted into bicarbonate, it is important to 
note that LR infusion with exogenous bicarbonate is contraindicated as the calcium 
contained within the LR solution can produce calcium carbonate which may precipitate 
out of solution.82 This reaction should be considered in patients where concurrent sodium 
bicarbonate administration is likely. Another potential complication associated with LR is 
hyponatremia, as the solution has a lower than physiological concertation of sodium.83 
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While we have established that in some cases lactate may be used as an energy source, 
studies in rats indicate that this benefit may be absent following traumatic brain injury. 84 
Finally, and perhaps most importantly, the administration of LR is contraindicated in 
patients with a potential traumatic brain injury as it can increase mortality in these 
patients.85 Following TBI, patients are at risk for the development of increased 
intracranial pressures (ICP). Hypotonic solutions such as LR can exacerbate increased 
ICP as the relatively high solute concentration within the cells draw in free water through 
osmotic gradients.58 For these reasons, patients with suspected TBI will not be included 
in the LR arm of the study. They will be included in the bicarbonate solution arm as this 
solution will be hypertonic. 
2.6 Bicarbonate Solution 
 The bicarbonate solution outlined previously is not commonly referred to in the 
literature despite being used commonly in surgical and emergency medical settings. The 
possible benefits of the solution stem from two key characteristics of the solution. The 
first proposed benefit is its relative hypertonic concentration. Using RxKinetics’ method 
for calculating osmolarity, the solution would contain approximately 431 mOsm/L.86 At 
this concentration, one liter of fluid contains as much solute as approximately 1.4 liters of 
normal saline. The benefits of hypertonic fluids are thought to be mediated by the 
mobilization of fluid in the extracellular and intracellular spaces into the vasculature, 
increasing intravascular volume, and improving perfusion.87 The other key attribute of 
this solution is the inclusion of bicarbonate, a key physiological buffer that can help 
combat acidosis and aid in recovery. 
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 The role of bicarbonate in acid-base balance is well established. Bicarbonate can 
react with free protons to generate compounds that can either be exhaled or excreted in 
the urine to maintain acid-base homeostasis.88 Bicarbonate reabsorption is performed 
primarily in the kidneys where some acid excretion also occurs.32 The supplementation of 
additional exogenous bicarbonate has been theorized to improve outcomes, however 
many studies have failed to demonstrate a mortality benefit. It is thought that the rapid 
administration of high concentrations of sodium bicarbonate can lead to the accumulation 
of carbon dioxide in the tissues leading to acidosis as the respiratory system is unable to 
clear the produced CO2 as quickly as it is produced.
89 Therefore, it’s reasonable to 
suspect that when given as an infusion, as is described in this study, we may be able to 
overcome the issue associated with pushing concentrated ampules of bicarbonate. A 
survey of clinicians in New Zealand and Australia indicated that the preferred 
administration of sodium bicarbonate in a study would be an infusion as opposed to a 
bolus of concentrated solution.90 While the use of concentrated bicarbonate solutions in 
acidotic patients is controversial, the use of buffered crystalloids solutions has shown 
benefit.62 The use of bicarbonate may be beneficial over lactate as a buffer as it does not 
require conversion into pyruvate and metabolism through glycolysis to generate the end 
product.58 The composition of the proposed solution may also contribute to a decrease in 
the exacerbation of acidemia. A study by Joseph et al found that with increases in the 
concentration of chloride (5% NaCl vs 3% NaCl) there tends to be a decrease in pH in 
trauma patients.91 The proposed solution contains only 65 mOsm/L of chloride which 
should help reduce the incidence of hyperchloremia.  
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 The proposed bicarbonate solution may also be beneficial in the reduction of 
inflammation in trauma patients. While no studies have been performed that observe the 
effects of bicarbonate or hypertonic fluids on inflammation in trauma patients in general, 
many studies have been performed that induce some form of hypoxic distress that may be 
used as an analog for the physiological response to trauma. A study on patients 
undergoing surgical repair of femur fractures found that pre-operative hypertonic fluids 
may attenuate the effects of polymorphonuclear leukocyte activity thereby reducing 
inflammation. 92 Another study by Junger et al found that hypertonic fluids given in the 
prehospital setting to patients suffering from hypovolemic shock may reduce 
inflammation by reducing the expression of certain cell-surface markers on neutrophils 
leading to reduced degranulation.93 In addition to attenuation of neutrophil function, 
hypertonic fluids have been shown to induce polymorphonuclear cell apoptosis in in vitro 
studies. 94 As discussed previously, a mediator of inflammation is a lack of end-organ 
perfusion. The use of hypertonic fluids (specifically in acutely alcohol-intoxicated 
patients) may be able to improve perfusion through the correction of arginine vasopressin 
(AVP) levels, indirectly increasing mean arterial blood pressure and potentially reversing 
end-organ hypoperfusion.95 Bicarbonate itself may also help reverse hypoxic 
inflammation, as studies in athletes showed that bicarbonate was effective at reducing the 
incidence of arterial oxygen desaturation. 96 A similar study conducted on cyclists found 
that bicarbonate improved acid-base balance recovery in hypoxic conditions.97 
 As stated earlier, LR is a poor choice in patients with TBI due to its low 
osmolality. As a slightly hypertonic solution that contains bicarbonate, the solution 
proposed in this study could incur mortality benefits in these patients. Studies in canine 
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models indicate that hypertonic solutions prevent the formation of cerebral edema as 
hypertonic solutions mobilize free water out of cells.98 In humans, hypertonic saline 
solutions were shown to reduce inflammation in trauma patients with TBI.99 Mannitol is 
generally considered the first-line treatment for patients with elevated intracranial 
pressure (ICP), however, a meta-analysis by Mortazavi et al found that saline-based 
hypertonic solutions may be more efficacious in these patients.100 The benefits of the 
solution may extend beyond the fact the solution is slightly hypertonic, as a study by 
Bourdeaux et al found that bicarbonate infusion over 30 minutes was more effective at 
reducing increased ICP than 5% NaCl solutions, indicating that bicarbonate itself may 
play a role in the reduction of ICP.101 
 Hypertonic solutions are also the preferred treatment for burn patients. One meta-
analysis found that patients receiving hypertonic fluid required less volume.102 A study in 
mice with severe burns indicated that hypertonic solutions reduced rates of pulmonary 
edema and hyponatremia and attenuated oxidative stress.103 A study in rats also supports 
the finding that hypertonic solutions can protect against lung injuries following burns 
through the inhibition of inflammatory pathways. Hypertonic saline was also found to be 
beneficial to the kidneys of rats that were severely burned by reducing renal edema and 
reducing hyponatremia.104 Studies have also shown reduced rates of intestinal edema in 
rats that experienced severe thermal injuries.105 
 End-organ benefits of the proposed solution may extend beyond burn patients. 
Certain surgical procedures such as endovascular aneurism repair are associated with 
acute kidney injury (AKI), however, the administration of bicarbonate and standard 
hydration has demonstrated protective effects when compared with adequate hydration 
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alone in these patients (95% CI of 0.05-0.89).106 Trauma patients frequently receive 
iodinated contrast during computed tomography scans in the secondary survey which has 
long been considered a risk factor for AKI.107 Patients that undergo percutaneous 
coronary interventions are also at risk for the development of AKI, and in this population 
hydration and bicarbonate are found to be effective strategies for limiting contrast-
induced kidney injury.108 Renal benefits of bicarbonate are also seen in patients with 
chronic kidney disease where it appears to incur a benefit on mortality and kidney 
function (Mortality RR adjusted 95% CI of 0.18-.074, 34% improvement in creatinine 
clearance, p-value <0.001) 109 Studies in rats with hemorrhagic shock that were 
resuscitated with blood and crystalloid had less kidney and liver damage when the fluid 
utilized was hypertonic.50 One study also demonstrated less lung injury in hemorrhaged 
rats that received hypertonic solutions through the upregulation of aquaporin activity.110 
Vascular endothelial function was also improved in human patients with chronic kidney 
disease when metabolic acidosis was treated with sodium bicarbonate.111 
 Isotonic solutions (normal saline) are generally considered the first-line 
management for trauma patients and in the cases where other solutions are used, they are 
usually hypotonic (LR). Despite this convention, there have been multiple studies that 
indicate that hypertonic solutions are not only safe but may also be more beneficial than 
solutions with lower tonicity. A study by Han et al found that solutions as high as 3% 
hypertonic saline solution (which is over twice as osmolar as the proposed solution) were 
safe in patients with hypovolemic shock.112 A meta-analysis of hypertonic solutions 
found that solutions as high as 7.5% NaCl (several times more concentrated than the 
proposed solution) do not increase mortality in trauma patients leading the authors of the 
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study to suggest that highly concentrated hypertonic solutions may be viable options for 
the resuscitation of trauma patients.113  Another review by Ertmer et al took it a step 
farther stating that “… administration of hypertonic solutions may exert beneficial effects 
beyond hemodynamic stabilization,” on trauma patients. There is sufficient evidence to 
suggest that the proposed bicarbonate solution is not only safe but possibly more 
effective than traditional solutions when used in the resuscitation of trauma patients.  
2.7 Review of Confounding Variables 
 There are few factors that influence both the effects of intravenous fluid and 
mortality, and a review of the literature did not reveal any clear confounding variables. 
Some factors that should be considered include the amount of fluid given in the 
prehospital setting, length of transport which may prolong definitive care and exacerbate 
acidosis, pre-existing diseases that influence acid-base balance such as chronic kidney 
disease and COPD, current medications that can influence acid-base balance such as 
acetazolamide or oral bicarbonate, and liver dysfunction which could impair lactate 
metabolism.114-117 Based on the design of the study as a randomized controlled trial with 
a large sample size, we expect to be able to control for both known and unknown 
confounding variables. 
2.8 Review of Relevant Methodology 
 This study is novel in several ways. Firstly, this is the first study comparing 
different crystalloid solutions in trauma patients to utilize mortality as the primary 
outcome. Secondly, this is the first study that will randomize and initiate the intervention 
in the field. Thirdly, this is the first study that will compare the proposed bicarbonate 
solution to commercially available crystalloid solutions. Due to the unique parameters of 
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this study, there will be a unique methodology implemented in the design, however many 
of the strategies utilized in similar studies can be adapted to work in this setting.  
2.8.1 Randomization, Inclusion and Exclusion Criteria, and Blinding 
 A study by Young et al published in 2014 is perhaps the closest in design to what 
is being proposed here. This small study randomized trauma patients to receive normal 
saline or Plasma-Lyte A.  Randomization was performed using a computer-generated 
randomization sequence in a 1:1 ratio. Solutions were covered in opaque wrappers and 
labeled with “study isotonic fluids” and a lot number and expiration date. They then 
placed thirty masked 1-L bags in suitcases that were assigned to the patient as the only 
source of crystalloid IV fluid for a 24-hour period. These principles will be modified and 
utilized in this study which will be described in the next chapter. Inclusion criteria were 
based on the triage criteria for severe acute injury at UC-Davis Medical Center, a level 1 
trauma center. These criteria included “penetrating injury to the neck, chest, abdomen, or 
pelvis; Glasgow Coma Scale scores less than 9 or deteriorating by 2 after injury; systolic 
blood pressure less than 90 mm Hg; pulseless, injured extremity; or need for endotracheal 
intubation.” They also included patients that required transfusion, surgery, or 
interventional radiology within 60 minutes of arrival to the hospital. Exclusion criteria 
included patients younger than 18 years of age, pregnant patients without apparent 
traumatic injury, patients on dialysis, incarcerated patients, and patients expected to 
expire within 48 hours.31 These will serve as the foundation for the exclusion and 
inclusion criteria in this study. 
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2.8.2 Statistical Significance and Power and Sample Size Calculation 
 In order to achieve adequate power and statistical significance, we will follow the 
same parameters as several other RCTs that use mortality as a primary outcome (in this 
case sepsis patients receiving care in the ICU). These studies generally utilize a power of 
80% with an alpha of 0.05. 118 As this study looks to evaluate mortality in critically ill 
trauma patients, we will include only patients that are found to have an injury severity 
score (ISS) 16 or greater in our analysis. Shi et al have found that patients with ISS scores 
of 16 or greater have a mortality rate of 12.6%.119 While there have not been any studies 
in trauma patients comparing mortality based on the choice of crystalloids, Raghunathan 
et al performed a retrospective cohort study in critically ill sepsis patients comparing 
normal saline to LR with in-hospital mortality as the primary outcome. They found a 
relative risk reduction of 14% (19.6% vs 22.8% mortality, RR of 0.86, 95% CI of 0.78 to 
0.94) in the patients receiving LR compared to those receiving exclusively non-balanced 
solutions (primarily normal saline).120 This expected mortality rate of 12.6% and a 
predicted relative risk reduction of 14% will be utilized to calculate our sample size. This 
will be discussed in the following chapter. We are expecting minimal to no loss to 
follow-up as the primary outcome is in-hospital mortality.  
2.8.3 Informed Consent in Emergency Research 
 Obtaining informed consent is an important part of studies utilizing human 
subjects. Unfortunately, patients that are critically injured and incapacitated as a result of 
traumatic injury may be unable to provide informed consent. Despite this concern, 
research is still required to improve the management of trauma patients in order to 
understand the best possible interventions to implement in these individuals. To address 
this hurdle, the Federal Drug Administration (FDA) has developed a policy known as the 
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Exception from Informed Consent (EFIC). The EFIC allows for a study to be conducted 
when there is the potential for clear benefit from the experimental intervention, but 
patients are unable to provide informed consent before the initiation of the intervention, 
such as the administration of intravenous fluid to correct hemodynamic instability. In 
order to protect patient autonomy, the FDA requires the engagement of the population 
that may be receiving the intervention through “community consultation” prior to the 
implementation of a study using EFIC. While the definition of community consultation is 
not clearly described it may include focus groups hosted at community organizations 
(such as churches or recreational centers) within the community where the study will take 
place or interviews of patients at participating hospitals to describe the rationale of the 
intervention and gauge their interest in participating in the study.121 A study by Dickert et 
al found that community consultation focus groups that were interactive tended to have 
higher percentages of participants to be in agreement with the EFIC protocol for their 
particular study. These participants had better knowledge of the study design and goals 
compared to participants that attended noninteractive consultations.122 This should be 
considered when organizing community consultation events although the exact threshold 
of what constitutes sufficient community consultation will be at the discretion of the 
institutional review board. In accordance with the FDA’s policy regarding EFIC, the 
findings of the study will be made publicly available.  
2.9 Conclusion 
 The “ABCs” (airway, breathing, and circulation) represent the essential 
components of the management of trauma patients. Circulation is perhaps the most 
elusive and confounding arm of this trinity, as hemodynamic compromise can arise from 
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a myriad of causes. For this reason, the administration of IV fluids to trauma patients 
represents a tenet of trauma management as it can quickly address circulatory 
dysfunction. Unfortunately, it is becoming more and more evident that the solution most 
typically utilized for fluid resuscitation, may in fact be contributing to severe metabolic 
derangements in these patients. The use of normal saline has been directly and indirectly 
implicated in the development of metabolic acidosis, end-organ dysfunction, 
coagulopathy, and electrolyte disturbances. Any of these factors on their own could 
represent an increased mortality risk for patients that are already critically ill.  
 This constellation of complications, however, may not represent a necessary evil 
that has long been thought to come with the territory of fluid resuscitation. There is 
evidence to suggest that the use of crystalloid solutions that contain buffers such as 
bicarbonate or lactate, may be able to achieve the same goal of maintaining 
hemodynamic integrity without the downside of the metabolic consequences that are 
imposed by normal saline.  
 To definitively answer the question of whether the choice of fluid can influence 
mortality in this critically ill population, a randomized control trial with a large sample 
size will be utilized. The scale and design of the study will account for confounders and 
heterogeneity amongst each of the three arms of the study. Current literature supports the 
need for this study, as mortality has not yet been used as a primary outcome when 
comparing fluid types. Both lactated ringer’s and the proposed sodium bicarbonate 
solution represent promising potential replacements for normal saline in trauma patients 
moving forward, each offering their own unique benefits. To carry out this study in a 
manner that is both highly ethical and scientifically rigorous, we will utilize the FDA’s 
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protocols regarding the Exception from Informed Consent with interactive community 
engagement and consultation.  
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Chapter 3: Methods 
3.1 Study Design 
We will perform a multi-centered, double-blind randomized controlled trial 
utilizing adult trauma centers and emergency medical services (EMS) in the state of 
Connecticut and New York City. Trauma patients will be randomized using computer-
generated randomization to either the control (normal saline) or one of the two 
intervention arms: lactated ringer’s (LR) or the sodium bicarbonate solution (SBS) 
described in chapter 2. Computer-generated randomization will include screening for 
patients with suspected traumatic brain injury (TBI) as LR may increase mortality in 
these patients.1 Patients with suspected TBI will be randomized to either normal saline 
(NS) or the sodium bicarbonate solution. Administration of the assigned fluid will take 
place during EMS transport and initial stabilization in the emergency department. Trauma 
patients being admitted will have blinded fluids discontinued upon arrival at their 
respective floor, at which point the overseeing provider will determine which fluid their 
patient will receive if any.  
3.2 Study Population, Setting, and Sampling 
3.2.1 Setting 
Trauma centers in Connecticut will include Hartford Hospital, St. Francis 
Hospital and Medical Center, and Yale-New Haven Hospital as well as smaller trauma 
centers throughout the state. The EMS company utilized will be American Medical 
Response (AMR) of Connecticut Inc, specifically crews capable of performing 
intravenous catheterization and administration of intravenous fluids. In New York, 
hospitals will include Elmhurst Hospital Center, Jacobi Medical Center, King’s County 
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Hospital Center, and other lower volume level I trauma centers. EMS services will 
include those that transport trauma patients to the aforementioned trauma centers.  
3.2.2 Population 
The study population will include adults 18 and older that meet at least one of the 
following criteria following traumatic injury: GCS under 12, those that require 
intubation, those with a pulseless extremity, penetrating trauma to structures proximal to 
the elbow or knee including the chest, neck, or abdomen, systolic blood pressure under 
90, MAP under 65 or diastolic blood pressure under 40, open fractures, and those that 
required surgery, interventional radiology, or blood products within two hours of arrival 
at the hospital. Patients will be excluded if they meet any of the following criteria: 
patients younger than 18 years of age, pregnant patients, patients on dialysis, incarcerated 
patients, and patients expected to expire within 48 hours.  
 Patients that meet the criteria for inclusion will be randomized to one of the three 
study arms, however, only patients that meet criteria and have an injury severity score 
(ISS) of 16 or greater, the cutoff for “severe trauma,” will be included in the analysis for 
outcomes. It should be noted that a patient’s specific ISS will not be known until a review 
of their medical record is performed following their discharge, as it is calculated 
retrospectively. 
3.2.3 Sampling 
 We will utilize total population sampling. The population will be defined as 
trauma patients with an ISS score of 16 or greater, who meet any of the inclusion criteria 
and none of the exclusion criteria who are treated at trauma centers in Connecticut or 
New York City.   
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3.3 Data Collection, Blinding, and Analysis 
3.3.1 Collection 
 Medical records of patients enrolled in the study will be examined by research 
staff that are blinded to the fluid that the subjects received. Patients will be assigned 
unique identification numbers in two separate databases. One database will identify the 
solution that the patient was randomized to, while the other will contain only the results 
of the medical record review. These data will be evaluated monthly to determine if there 
are significant unanticipated trends that would precipitate premature discontinuation of 
the trial.  
3.3.2 Sample Size Calculation 
 Based on our review of the literature we estimate a mortality rate of 12.6% in the 
control arm of the study. Based on other studies comparing balanced crystalloids in 
critically ill patients we believe that it is reasonable to expect a 14% relative risk 
reduction in both experimental arms of the study. We will use a significance level of 
p<.05 with a power of 0.80. Based on these proportions (P1 = 10.8%) we calculate that 
the study will require 5,004 patients per arm of the study for a total enrollment of 15,012 
patients. Screenshots of the data input into the calculator will be available in Appendix B. 
3.3.3 Blinding of Fluids and Assignment of Intervention 
 Fluids will be blinded to the participants and investigators using opaque wrappers 
indicating their expiration date, lot number, and their designation as “study IV fluid”. 
Fluids will be kept in one of two plastic bins (A and B). Bin A will contain all three 
fluids, divided into three sections (1A, 2A, and 3A). Bin B will contain only normal 
saline and the sodium bicarbonate solution, divided into two sections (1B and 2B). 
Patients with suspected TBI will be randomized to receive fluids from bin “B”. All other 
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trauma patients that meet the criteria will be randomized to receive fluid from bin “A”. 
The contents of each respective bin will be rotated daily. The contents of each bin will be 
blinded to EMS and hospital staff, but each bin will be standardized across systems based 
on a written schedule. Table 1 is an example of what a daily randomization schedule may 
look like over the course of a 3-day period. 
Table 1. Randomization of study fluids in respective bins 
Date 1A 2A 3A 1B 2B 
06/01/2022 LR NS SBS SBS NS 
06/02/2022 NS LR SBS SBS NS 
06/03/2022 SBS LR NS NS SBS 
 Randomization of the patients to their respective study arms will be conducted in 
the field when subjects are determined to meet inclusion criteria. EMS staff will be able 
to utilize a mobile phone application or website that will randomly assign the subject to 
the control arm or one of the experimental arms. The randomization program will prompt 
EMS providers to acknowledge if there is suspicion of a TBI. If there is no suspicion of 
TBI then the patient will be randomized to a solution in the “A” bin. In the case that there 
is a concern for TBI the program will randomize the patient to one of the two fluids in the 
“B” bin.  
3.3.4 Blinding of Outcomes 
 Members of the research team that are responsible for analyzing the primary and 
secondary outcomes of the study will be blinded to the fluid that the subjects receive. 
They will be provided with de-identified patient medical records and will be asked to 
collect data regarding mortality, time to discharge (when applicable), time to extubation 
(when applicable), the need for blood products within 24 hours, and ISS. 
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3.3.5 Adherence and Follow Up  
 The outcomes of interest of this study are generally thoroughly documented in the 
medical record and should be easily accounted for during hospitalization. Administration 
of the intervention will occur within minutes to hours of initial injury under the 
supervision of EMS and ED providers. For this reason, we do not expect any issues with 
adherence or follow-up. 
3.3.6 Study Variables and Measures 
 The independent variable in this study will be the fluid that subjects are 
randomized to (NS, LR, or SBS), this will be recorded by EMS providers in the field. 
SBS and LR will be considered the intervention arms of this study. Dependent variables 
will include in-hospital mortality (primary outcome), need for intubation, duration of 
intubation (in days), need for blood products, and hospital stay (in days). These outcomes 
will be measured following discharge by research staff following a review of the medical 
record. These data will be gathered using the form in Appendix C. At this time, we have 
not identified any known confounders, and the study design should account for unknown 
confounding variables. 
3.3.7 Analysis 
 The primary outcome of mortality will be analyzed using chi-square analysis. 
Secondary outcomes of time to extubation and time to discharge will be analyzed using 
Cox proportional hazards regressions. The other secondary outcome, the need for blood 
products, will be analyzed using chi-square analysis. While this study is designed to be 
large enough to control for confounding effects, descriptive statistics will be collected 
from medical record review to identify any factors that may influence outcomes outside 
of the intervention. These descriptive statistics will include age, BMI, sex, transport time, 
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comorbidities, initial GCS, total IV fluid volume administered, and ISS. Analysis will 
follow the intention to treat principle although it should be noted that based on the close 
supervision associated with the design of the study it is unlikely that there would be 
different results from per-protocol analysis.  
3.3.8 Timeline and Resources 
 The study period will last 21 months unless the sample size is met earlier. Based 
on the data available from the state of Connecticut from 2000-2004 and 2008-2013 it is 
reasonable to expect more than 20,000 injury-related admissions and/or deaths per 
year.2,3 Publicly available data from New York City from 2010-2013 demonstrates that 
there are on average approximately an additional 2,240 patients a year that meet inclusion 
criteria based on ISS (likely substantially more than that that did not have ISS recorded)4. 
Based on those data the full 21-month trial period may not be required. The study will 
begin in April of 2022 and run through December of 2023 unless adequate sample size is 
met before that point, with three months between January and March of 2022 reserved for 
community consultation (discussed below).  
 A study of this scale will be a significant undertaking. A small office will be 
required for the research staff to analyze data. Warehouse space will be required for the 
preparation of bins with appropriately randomized fluids. A distribution network will 
need to be in place to deliver appropriately blinded bins to EMS stations and hospitals as 
necessary. EMS providers will need to be trained on randomization and data collection. A 
pharmacist may be required to oversee the preparation of the SBS mixture. The sodium 
bicarbonate solution is not available commercially and will need to be made by adding 
150 mL of 8.4% sodium bicarbonate to 850 mL of 0.45% NaCl to reach a final 
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concentration of approximately 1.3%. A program will need to be written or adapted for 
ease of randomization in the field. Software will be required to de-identify patient 
information and perform statistical analysis while maintaining HIPAA standards 
regarding confidentiality. Fluids and bicarbonate solutions will need to be sourced from 
the manufacturer.  
3.4 Ethical Approval 
3.4.1 Subject Protection and Confidentiality and the Exception from Informed 
Consent 
 Prior to the initiation of the study, we will receive approval from the institutional 
review board (IRB) of Yale University and the appropriate review boards associated with 
participating hospitals. The application to the committee will include the necessary 
documentation as outlined in the IRB guidelines titled “100 PR.1 Review by a Convened 
Institutional Review Board (IRB)”. These guidelines outline the documentation required 
for approval by the IRB, including but not limited to: application, recruitment plan, 
proper health insurance portability and accountability act (HIPAA) documentation, and 
protocols. Additionally, a clear consent form that includes potential risks to subjects will 
be provided. This form can be found in Appendix A.  
 Obtaining consent will not always be feasible in the population, as some patients 
will be incapacitated as a result of their traumatic injuries. For this reason, the study will 
utilize the Food and Drug Administration’s (FDA) Exception from Informed Consent 
(EFIC). Yale University’s guidelines for EFIC are outlined in IRB documents titled “200 
PR.2 Exception from Informed Consent Research.” The document outlines nine factors 
that are required for IRB approval; 1. Concurrence by an Independent Physician, 2. Life-
Threatening Situation, 3. Informed Consent Not Feasible, 4. Prospect of Direct Benefit, 5. 
47 
 
Research Impracticable in Absence of Waiver of Informed Consent, 6. Therapeutic 
Window, 7. Plan to Contact Legally Authorized Representative/Surrogate, 8. Informed 
Consent Procedures and Documents, and 9. Additional Protections (including community 
consultations and the establishment of an independent data monitoring committee to 
exercise oversight of the research and proper public disclosures). 
  In order to meet the requirements for community consultations, we will hold 
interactive open forums in the cities surrounding the state of Connecticut and in New 
York City. Forums in Connecticut will be primarily focusing on New Haven and Hartford 
Counties.  Forums in New York City will be carried out in areas near participating 
hospitals. These sessions will be made available at community sites such as recreation 
centers, hospitals, and community centers throughout Connecticut and New York City. 
There will be five open forums in New York and an additional five in Connecticut with 
three of the five being held in New Haven or Hartford county. At least one forum will be 
held in Fairfield county, to include patients that may receive care at Bridgeport or St. 
Vincent’s Hospital. These sessions will be heavily advertised throughout the community 
and participation will be encouraged by community members. Surrounding communities 
will be encouraged to attend as well. We will describe the goals of the study along with 
supporting rationale and potential risks. The forum will give community members an 
opportunity to ask questions and participate in the discussion. In accordance with the 
FDA’s guidelines regarding EFIC, we will also hold public community sessions 
following the completion of the trial in order to share the results of the study.  
 All patients that meet study criteria will be opted in by default. For those that are 
not able to provide consent, a legally authorized representative (LAR) will be informed 
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and will be given the opportunity to opt the patient out of the study if they wish to do so. 
Patients that have the ability to make their own medical decisions will be able to opt-out 
at any time. Patient information will be de-identified and stored on encrypted servers that 
meet standards as described in HIPAA. Patients will be given documentation outlining 
their rights under HIPAA before obtaining consent by patients or their LAR. HIPAA 
protocols will be followed by the research team. Patient information such as outcome and 
treatment arm will only be available to research staff responsible for gathering data 
within the medical record.  
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Chapter 4: Conclusions  
4.1 Advantages and Disadvantages  
As with any study, the study proposed above has its own strengths and 
weaknesses. Strengths of the study include its external validity, the practicality of the 
intervention, and study design and sample size. Weaknesses include the need for a large 
number of resources, complexity with coordination and implementation, and the limited 
number of fluids being compared. 
The study was designed to have extremely high levels of external validity, as the 
goal of this research is to identify the benefit of certain buffered solutions in all trauma 
patients. Because nearly all trauma patients can be included in this study with relatively 
broad inclusion criteria, we would expect to enroll patients with several different 
mechanisms of injury as well as varying degrees of injury severity. In addition to the 
generalizability of the study, one of the major strengths of the intervention is its overall 
cost-effectiveness. All proposed study fluids are commonly used and relatively cost-
effective. If the intervention is shown to be beneficial then it is unlikely that there would 
be significant hurdles in implementing a new solution as the standard of care nationwide. 
Finally, the study’s design as a randomized controlled trial at multiple hospitals with a 
large number of patients will allow us to control for unforeseen confounders while also 
helping to identify any potential benefit that may be incurred by the intervention. 
While the study was designed to limit disadvantages as much as possible, there 
are inherent challenges associated with designing a study of this scale. Perhaps the most 
notable of these challenges is the sheer number of resources that will be required to carry 
out this study. As this is a large multi-centered trial there will be challenges associated 
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with distribution to sites while maintaining appropriate blinding. We will require a large 
staff for intervention logistics, community consultation for the Food and Drug 
Administration’s (FDA) Exception for Informed Consent (EFIC), and data monitoring 
and statistical analysis. In addition to these resources, there will be challenges associated 
with coordination and implementation. EMS crews will need to be trained on 
randomization of the intervention and proper documentation, sites will need to remain 
consistent with the bin blinding protocols, data will have to be collected from multiple 
sites, and there must be coordination between hospital and EMS crews to maintain 
continuity of the intervention. Finally, this study is only designed to evaluate two 
buffered fluids compared to normal saline. There are a number of strong candidates for 
IV fluid resuscitation that may be safer and more effective than normal saline, such as 
Plasma-Lyte or colloids. Unfortunately, it simply isn’t practical in a study this large to 
include more than a few solutions. Perhaps at some time in the future, this study design 
could be adapted to evaluate other solutions.  
4.2 Clinical Significance 
 Trauma is the leading cause of death in children and young adults.1 Some of the 
deaths associated with trauma are unfortunately unavoidable, such as those that occur 
immediately following a traumatic event, however, there are a significant proportion of 
deaths that occur following initial stabilization in the ED.2 It is unclear how many of 
these deaths are a direct result of metabolic derangements such as metabolic acidosis, but 
there is sufficient evidence to suggest that the metabolic effects imposed by normal saline 
may detrimentally contribute to certain homeostatic functions such as pH balance and 
hemostasis which can indirectly contribute to mortality.3 These physiological effects are 
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thought to be the result of the composition of normal saline as a solution and they can 
potentially be mitigated through the use of buffered solutions that have more favorable 
metabolic profiles.4 
 The alternative solutions proposed in this study are widely used and are generally 
quite safe and cost-effective. By adding buffers such as lactate or bicarbonate, we hope to 
reduce some of the dilution of intrinsic buffers that occurs with normal saline, and the 
lower concentration of chloride as the primary anion may help reduce some of the strong 
ion effects that are also believed to contribute to acidosis. These solutions are quite 
inexpensive and offer volume expansion to maintain hemodynamic stability while 
hopefully reducing the metabolic effects associated with normal saline.  
 These proposed interventions could quite possibly change the standard of care for 
trauma patients. As trauma is such a common cause of mortality, the ramifications of this 
study could be enormous. While it is certainly possible that we may not see a significant 
change in overall mortality in these patients, the prospect of a cheap and effective therapy 
that has the potential to save countless lives is well worth it to attempt a study of this 
scale, as daunting as it may seem.  
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Appendix A: COMPOUND AUTHORIZATION AND CONSENT FOR 
PARTICIPATION IN A RESEARCH STUDY 
 
YALE UNIVERSITY 
YALE UNIVERSITY SCHOOL OF MEDICINE 
YALE-NEW HAVEN HOSPITAL 
 
 
Study Title: Back to Basics: The Effects of Buffered Crystalloids on Mortality in the 
Setting of Severe Trauma 
Principal Investigator: Adrian Maung MD 
Co-Investigator: D. Seth Murphy PA-SII 
 
Research Study Summary: 
• We are asking you to join a research study. 
• The purpose of this research study is to investigate whether intravenous (IV) fluid 
solutions that contain lactate or bicarbonate will reduce mortality in patients that 
suffer from severe physical trauma. 
• Study procedures will include: Patients that suffer from extreme trauma generally 
receive IV fluids to help maintain their blood pressure. In this study, we will 
randomize the contents of the fluids that patients receive. 
• 0 visits are required outside of the initial hospitalization. 
• There are some risks from participating in this study. Risks of the study include 
fever, pain, infection at the IV site, blood clots in the vein, cramps, and 
irritability.  
• The study may have no benefits to you. This study may help reduce the risk of 
mortality for patients that suffer severe physical trauma.  
• There are other choices available to you outside of this research. If you choose not to 
participate in the study, you may still require IV fluids following trauma, as this 
is a standard of care. The difference is that the fluid you receive will be selected 
by your provider. 
• Taking part in this study is your choice. You can choose to take part, or you can 
choose not to take part in this study.  You can also change your mind at any time.  
Whatever choice you make, you will not lose access to your medical care or give up 
any legal rights or benefits.  
• If you are interested in learning more about the study, please continue reading, or 
have someone read to you, the rest of this document. Take as much time as you need 
before you make your decision. Ask the study staff questions about anything you do 
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not understand. Once you understand the study, we will ask you if you wish to 
participate; if so, you will have to sign this form. 
 
Why is this study being offered to me? 
We are asking you to take part in a research study because You have met our study 
criteria for patients that suffer from severe physical trauma.  We are looking for 
15,012 participants to be part of this research study. 
Who is paying for the study? 
N/A 
Will I be paid for this study? 
Study participants will not receive financial compensation. 
Who is providing other support for the study? 
Yale School of Medicine  
What is the study about?  
The purpose of this study is to evaluate whether the use of fluids that contain bicarbonate 
or lactate can reduce mortality rates in patients that suffer from severe physical trauma.  
What are you asking me to do and how long will it take?  
If you agree to take part in this study, this is what will happen: This study will not require 
any additional work from you, the study participant. If you participate in this study you 
will receive intravenous (IV) fluid as you normally would to help maintain your blood 
pressure. The fluid that you receive will be randomly selected by a computer, much like 
pulling a name out of a virtual hat. Participants will receive one of three different types of 
fluids. Some patients will receive “Normal Saline” (0.9% sodium chloride). Other 
patients will receive solutions with “buffers”. These solutions are Lactated Ringer’s 
solution or 0.45% sodium chloride with sodium bicarbonate. The buffers in these 
solutions are lactate and bicarbonate respectively. Buffers are solutions that help maintain 
acid-base balance.  
After participants receive these fluids in the ambulance and the emergency room, the 
remainder of their hospital stay will proceed as it normally would. We will collect data 
from the participant's medical records including whether the participant survived their 
hospital stay, how long the patient was in the hospital, if the patient required blood, if the 
patient needed a breathing tube (intubation), and how long the patient required the 
breathing tube.  
Results of our study will be made publicly available. 
What are the risks and discomforts of participating?  
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The most common foreseeable risk of the study is pain or discomfort at the IV site. All of 
the medications and fluids in this study are generally well tolerated. Rare risks include 
shortness of breath, infection at the IV site, and blood clots at the IV site. These can be 
managed in the hospital during your admission at the discretion of your provider but may 
require supplemental oxygen, antibiotics, and anticoagulants (medication to resolve blood 
clots) respectively. Patients that receive bicarbonate may experience irritability.  
How will I know about new risks or important information about the study?  
We will tell you if we learn any new information that could change your mind about 
taking part in this study.  
Results of this study will be made publicly available when it has been compiled and 
evaluated. 
How can the study possibly benefit me? 
We suspect that the intervention arms of this study (either of the fluids that contain 
buffers) may reasonably reduce the rate of mortality in patients that suffer from severe 
trauma. It is possible that you may have improved outcomes if you are randomized to one 
of these intervention arms. 
How can the study possibly benefit other people? 
In the future, this study may influence the way that trauma patients are treated with IV 
fluids. If findings are statistically significant this study could drastically improve the 
outcomes of trauma patients going forward. 
Are there any costs to participation?  
If you take part in this study, you will not have to pay for any services, supplies, study 
procedures, or care that are provided for this research only (they are NOT part of your 
routine medical care).  However, there may be additional costs to you for medical costs 
that are not related to your IV fluids.  
Instead of participating in this study, you have some other choices.  
You could:  
• Get treatment without being in a study. This would most likely include 
receiving normal saline, which is one of the fluids included in this study. This 
determination would ultimately be made by your provider in the ambulance 
or hospital.  
 
How will you keep my data safe and private? 
We will keep the information we collect about you confidential. We will share it with 
others if you agree to it or when we have to do it because U.S. or State law requires it. 
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For example, we will tell somebody if we learn that you are hurting a child or an older 
person. 
Information will be stored in encrypted and password protected in secure servers. 
When we publish the results of the research or talk about it at conferences, we will not 
use your name. If we want to use your name, we would ask you for your permission.   
We will also share information about you with other researchers for future research but 
we will not use your name or other identifiers. We will not ask you for any additional 
permission. 
We will not be collecting or storing any specimens from this study. 
What information will you collect about me in this study? 
 
The information we are asking to use and share is called “Protected Health Information.” 
It is protected by a federal law called the Privacy Rule of the Health Insurance Portability 
and Accountability Act (HIPAA). In general, we cannot use or share your health 
information for research without your permission. If you want, we can give you more 
information about the Privacy Rule. Also, if you have any questions about the Privacy Rule 
and your rights, you can speak to Yale Privacy Officer at 203-432-5919. 
 
The specific information about you and your health that we will collect, use, and share 
includes: 
 
• Research study records 
• Medical and laboratory records of only those services provided in connection with 
this Study.   
• The entire research record and any medical records held by participating hospitals 
created from: The date of your hospital admission to: your discharge date  
• Records about phone calls made as part of this research 
• Records about your study visits 
• Information obtained during this research regarding 
▪ Whether you survived your hospitalization  
▪ Medical records describing the severity of your injuries 
▪ Whether or not you required blood transfusion 
▪ Basic blood cell counts and complete metabolic panels to monitor 
for adverse events 
▪ Whether you required a breathing tube and how long it was in place 
▪ When you were discharged from the hospital 
 
 
How will you use and share my information? 
We will use your information to conduct the study described in this consent form.  
We may share your information with: 
• The U.S. Department of Health and Human Services (DHHS) agencies 
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• Representatives from Yale University, the Yale Human Research Protection 
Program and the Institutional Review Board (the committee that reviews, approves, 
and monitors research on human participants), who are responsible for ensuring 
research compliance.  These individuals are required to keep all information 
confidential.  
• The U.S. Food and Drug Administration (FDA) This is done so that the FDA can 
review information about the IV fluids involved in this research.  The information 
may also be used to meet the reporting requirements of drug regulatory agencies.   
• Drug regulatory agencies in other countries 
• Health care providers who provide services to you in connection with this study 
• Laboratories and other individuals and organizations that analyze your health 
information in connection with this study, according to the study plan. 
• Principal Investigator of the study 
• Co-Investigators and other investigators  
• Study Coordinator and Members of the Research Team  
• Data and Safety Monitoring Boards and others authorized to monitor the conduct of 
the Study  
 
We will do our best to make sure your information stays private. But, if we share 
information with people who do not have to follow the Privacy Rule, your information will 
no longer be protected by the Privacy Rule. Let us know if you have questions about this. 
However, to better protect your health information, agreements are in place with these 
individuals and/or companies that require that they keep your information confidential. 
 
Why must I sign this document? 
By signing this form, you will allow researchers to use and disclose your information 
described above for this research study. This is to ensure that the information related to this 
research is available to all parties who may need it for research purposes. You always have 
the right to review and copy your health information in your medical record.  
 
However, this is a double-blinded treatment study and if you sign this permission form, 
you will not be allowed to look at or copy your study-related information until after the 
research is completed.    
 
What if I change my mind? 
The authorization to use and disclose your health information collected during your 
participation in this study will never expire.  However, you may withdraw or take away 
your permission at any time. You may withdraw your permission by telling the study staff 
or by writing to Dr. Adrian Maung at the Yale University, New Haven, CT 06520. 
 
If you withdraw your permission, you will not be able to stay in this study but the care you 
get from your doctor outside this study will not change.  No new health information 
identifying you will be gathered after the date you withdraw. Information that has already 
been collected may still be used and given to others until the end of the research study to 




What if I want to refuse or end participation before the study is over?  
Taking part in this study is your choice. You can choose to take part, or you can choose 
not to take part in this study.  You also can change your mind at any time.  Whatever 
choice you make, you will not lose access to your medical care or give up any legal rights 
or benefits.  
We would still treat you with standard therapy or, at your request, refer you to a clinic or 
doctor who can offer this treatment. Not participating or withdrawing later will not harm 
your relationship with your own doctors or with this institution.   
To withdraw from the study, you can call a member of the research team at any time and 
tell them that you no longer want to take part.   
The researchers may withdraw you from participating in the research if necessary. You 
may be withdrawn from the study, for example, if you experience an unforeseen 
complication. 
What will happen with my data if I stop participating? 
If you choose to withdraw from the study, data that has already been collected may still 
be used in the study, however, no new data will be collected. 
Who should I contact if I have questions?  
Please feel free to ask about anything you don't understand.  
If you have questions later or if you have a research-related problem, you can call the 
Principal Investigator at  (203) 432-4771  
If you have questions about your rights as a research participant, or you have complaints 
about this research, you call the Yale Institutional Review Boards at (203) 785-4688 or 
email hrpp@yale.edu. 
A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as 
required by U.S. Law. This Web site will not include information that can identify you. 
At most, the Web site will include a summary of the results. You can search this Web site 
at any time. 
Authorization and Permission 
 
Your signature below indicates that you have read this consent document and that you 
agree to be in this study.   




Participant Printed Name  Participant Signature  Date 
Printed Name of Legally 
Authorized Representative (if the 
participant is unable to consent) 
 Signature of Legally Authorized 
Representative 
 Date 
Person Obtaining Consent Printed 
Name 

































Appendix C: Clinical Trial Participant Data 
To be initiated by EMS staff and given to documenting trauma RN 
 
EMS Staff 
• Fluid Bin (Circle one) A/B Fluid Number (Circle one) 1/2/3 
• Date _______ 
• Transport Time ___________ 
• Initial GCS ____________ 
• Fluid Volume given by EMS (in mL) _______ 
 
Documenting Trauma RN 
• Patient MRN ___________ 
• Fluid Volume given in ED ONLY ______ 
Research Assistant  
• Patient Age ________ 
• Patient Sex ________ 
• Patient BMI _______ 
• Injury Severity Score (ISS) ______ 
• Comorbidities  
o Diabetes 
o Hypertension 
o Coagulopathy (specify if known) _____ 
o CAD 
o Other heart disease (specify) _____ 
• Did patient survive to discharge? (Yes/No) 
• Did patient require intubation? (Yes/No) 
• If yes, how long was the patient intubated (in days) ____ 
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